logo
Another Royal Caribbean cruise outbreak hits 140+ passengers. Are outbreaks getting worse?

Another Royal Caribbean cruise outbreak hits 140+ passengers. Are outbreaks getting worse?

Yahoo4 days ago
2025 has already seen as many cruise ship outbreaks as all of last year. Is this the new normal?
More than 140 passengers and crew members aboard Royal Caribbean's Navigator of the Seas fell ill with gastrointestinal symptoms during a week-long cruise that ended July 11, marking yet another outbreak in what's shaping up to be a particularly challenging year for the cruise industry.
The outbreak affected 134 of the ship's 3,914 passengers — roughly 3.4% of those aboard — along with seven crew members out of 1,266 total crew. Passengers experienced the familiar trio of cruise ship illness symptoms: vomiting, diarrhea, and abdominal cramps. The Navigator of the Seas had departed Los Angeles on July 4 for a round-trip voyage to Mexico, making three stops before returning to port, where the outbreak was officially reported to the Centers for Disease Control and Prevention.
What makes this outbreak particularly concerning isn't just the numbers — it's the broader trend. We're only halfway through 2025, and this incident brings the year's total cruise ship gastrointestinal outbreaks to 18, already matching the entire total for 2024. That's a significant jump from the 14 outbreaks recorded in 2023. Is this the future of cruising?
A troubling pattern in the U.S.
The CDC tracks these incidents carefully, but only reports outbreaks that meet specific criteria: the ship must be under Vessel Sanitation Program jurisdiction (operating voyages that include both U.S. and foreign ports) and at least 3% of passengers or crew must report gastrointestinal symptoms to the ship's medical staff. This means the Navigator of the Seas outbreak, at 3.4% of passengers affected, just barely crossed the threshold for public notification.
Most of these outbreaks stem from norovirus, the highly contagious stomach bug that spreads rapidly in enclosed environments. The CDC noted in April that "a newly dominant strain is currently associated with reported norovirus outbreaks on land," and ships typically mirror land-based outbreak patterns. This suggests the current surge may reflect broader public health trends rather than cruise-specific problems. But that's not great news, either.
For the record, Royal Caribbean implemented enhanced sanitation protocols and isolated sick passengers and crew members during the voyage. The company emphasized that "the health and safety of our guests, crew, and the communities we visit are our top priority," noting their cleaning procedures exceed public health guidelines. However, the CDC has yet to identify the causative agent behind this latest outbreak.
The streak continues — across all cruise lines
This isn't Royal Caribbean's first outbreak rodeo this year. The cruise line has been dealing with multiple outbreaks across its fleet, joining other major operators like Holland America Line, Princess Cruises, and Cunard in facing similar challenges. Earlier this year, a Cunard luxury liner experienced an outbreak affecting more than 240 passengers and crew during a monthlong international voyage, while Princess Cruises saw over 80 people fall ill during a 16-night cruise in February.
The timing of these outbreaks raises questions about whether cruise lines are adequately prepared for what appears to be a particularly virulent norovirus season. While companies have implemented enhanced cleaning protocols and isolation procedures, the close quarters and shared facilities aboard cruise ships create ideal conditions for rapid transmission of gastrointestinal illnesses.
Are cruises... actually safe?
Despite the alarming headlines, perspective matters. The Navigator of the Seas carried nearly 4,000 passengers, and while 134 falling ill sounds significant, it represents a relatively small percentage of the total. For comparison, norovirus outbreaks occur regularly on land — in schools, nursing homes, and restaurants — but cruise ships draw more attention because they're self-contained environments where outbreaks can be easily tracked and reported.
The CDC emphasizes that cruise ship outbreaks represent only 1% of all reported gastrointestinal outbreaks. However, the concentrated nature of cruise ship populations means that when outbreaks do occur, they can affect a substantial number of people in a short timeframe.
For prospective cruisers, the key is understanding that while these outbreaks are concerning, they remain relatively rare events. The cruise industry serves millions of passengers annually, and the vast majority complete their voyages without incident. That said, the uptick in reported outbreaks suggests passengers should be particularly vigilant about hand hygiene and other preventive measures, especially during peak norovirus seasons.
The real question isn't whether cruises are safe — they generally are, all things considered. Instead, we should be asking whether the industry is doing enough to adapt to evolving public health challenges (never mind sustainability) and whether current protocols are sufficient to handle increasingly virulent strains of common illnesses. Because in 2025, there's work to be done.
Solve the daily Crossword
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

NFL bans smelling salts, saying product can mask concussion symptoms
NFL bans smelling salts, saying product can mask concussion symptoms

Yahoo

time10 minutes ago

  • Yahoo

NFL bans smelling salts, saying product can mask concussion symptoms

SANTA CLARA, Calif. (AP) — The NFL is banning the use of 'smelling salts' during games, saying the products aren't proven to be safe and also could mask signs of a concussion. The league sent a memo to teams on Tuesday explaining the decision to ban smelling salts and any other ammonia inhalant during pregame activities, games and halftime on the sideline or locker rooms. 'In 2024, the FDA issued a warning to companies that produce commercially available ammonia inhalants (AIs), as well as to consumers about the purchase and use of AIs, regarding the lack of evidence supporting the safety or efficacy of AIs marketed for improving mental alertness or boosting energy,' according to the memo obtained by The Associated Press. 'The FDA noted potential negative effects from AI use. AIs also have the potential to mask certain neurologic signs and symptoms, including some potential signs of concussion. As a result, the NFL Head, Neck, and Spine Committee recommended prohibiting the use of AIs for any purpose during play in the NFL.' San Francisco 49ers tight end George Kittle first disclosed the ban during an interview with NFL Network on Tuesday, adding that he hoped the league would relent and "figure out a middle ground.' That won't happen, according to the memo, which explicitly prohibits any club personnel from providing or supplying products such as ammonia capsules, inhalers, ammonia in a cup, and any form of 'smelling salts.' Smelling salts and other similar products have been a staple on NFL sidelines for years with many players believing they can provide a sudden jolt of energy or alertness. ___ AP NFL: Josh Dubow, The Associated Press

The US is Leaving UNESCO: Here's What Comes Next
The US is Leaving UNESCO: Here's What Comes Next

Condé Nast Traveler

time12 minutes ago

  • Condé Nast Traveler

The US is Leaving UNESCO: Here's What Comes Next

Iconic sites like the Statue of Liberty and Grand Canyon are among the 26 UNESCO World Heritage sites in the United States that stand to be affected by the Trump administration's July decision to withdraw from the United Nations-backed organization at the end of next year. President Trump announced the US' withdrawal from UNESCO in late July, claiming the organization 'works to advance divisive social and cultural causes' that are at odds with the administration's 'America First' foreign policy. UNESCO, which stands for the United Nations Educational, Scientific and Cultural Organization, is tasked with preserving more than 1,200 World Heritage sites around the globe, which are considered by the agency to have 'outstanding universal value.' They include some of the world's most popular travel destinations like the pyramids of Giza, Machu Picchu, and the Great Barrier Reef. For the 19 US National Park Service-managed parks and monuments that have also been granted UNESCO World Heritage status, the news of UNESCO's withdrawal comes on the heels of sweeping staff layoffs and federal funding cuts that impact America's popular public lands. 'This is just one more backwards step,' says Brenda Barrett, a representative for the nonprofit Coalition to Protect America's National Parks.

Your Wegovy May Pay for Itself
Your Wegovy May Pay for Itself

Wall Street Journal

time13 minutes ago

  • Wall Street Journal

Your Wegovy May Pay for Itself

The Roaring '20s spawned two of the most important medications ever: insulin and penicillin. The 2020s may repeat this feat with another incredible medical innovation—GLP-1 weight-loss therapies. Drugs like Zepbound (Eli Lilly) and Wegovy (Novo Nordisk) are delivering phenomenal results in a country where some 75% of adults are overweight or obese. But with GLP-1 list prices exceeding $1,000 a month, most employers have declined to cover the drugs for weight loss—leaving roughly 100 million beneficiaries to look for ways to pay themselves. Politicians have responded with outrage. The Inflation Reduction Act of 2022 added GLP-1s to the list of medications subject for Medicare price negotiation. President Trump has demanded price parity with what other countries have negotiated, and last week he said he would 'deploy every tool in our arsenal' if pharmaceutical companies don't lower prices. Connecticut is seeking federal approval to produce generic versions, despite patent protection until the 2030s. But the market has beaten politicians to the punch. Although most employers aren't covering GLP-1s, demand remains high. A PwC survey this year found that 30% to 35% of Americans are interested in using them. In response, Eli Lilly and Novo Nordisk have launched direct-to-consumer cash pricing for Zepbound and Wegovy. Without the middleman of health insurance, these out-of-pocket prices are now $499 a month. Competition has pushed prices down, and with new therapies on the horizon they are likely to keep falling.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store